Genotype-guided switch from ravulizumab to satralizumab in aquaporin-4–IgG–positive neuromyelitis optica spectrum disorder: a case of C5 polymorphism-associated ravulizumab resistance
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Multiple Sclerosis Research Studies
Complement system in diseases
Peripheral Neuropathies and Disorders
Publication details
- Journal / source
- Neurological Sciences
- Volume
- 47
- Issue
- 4
- Publication date
- 28 March 2026
- Language
- EN